ORIGINAL RESEARCH
Accepted on 26 May 2025
Bioinformatics Analysis Identifies ZBTB16 as a Potential Immune Biomarker for Lung Cancer and Pan-Cancer
doi 10.3389/fgene.2025.1541732
- 122 views
- Frontiers in Genetics
- Cancer Genetics and Oncogenomics
- Research Topics
- Mechanisms of Resistance to Immunotherapy and Targeted Therapy and Predictive Biomarkers in Non-small Cell Lung Cancer
Mechanisms of Resistance to Immunotherapy and Targeted Therapy and Predictive Biomarkers in Non-small Cell Lung Cancer
2,022
Total downloads
7,684
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 26 Mar 2025
Multi-omics pan-cancer analysis reveals the diagnostic and prognostic value of C8orf76, with experimental validation of its impact on lung adenocarcinoma cell proliferation
doi 10.3389/fgene.2025.1524422
- 877 views
ORIGINAL RESEARCH
Published on 12 Dec 2024
Descriptive analysis of durvalumab use in unresectable stage III non-small cell lung cancer in patients treated in Quebec’s University teaching hospitals
doi 10.3389/fonc.2024.1506172
- 823 views
CASE REPORT
Published on 20 Sep 2024
Case report: Intrapleural plus systemic Tislelizumab injection combined chemotherapy in RET gene fusion-positive lung adenocarcinoma presenting refractory malignant pleural effusion
doi 10.3389/fonc.2024.1404173
- 973 views
- 1 citation
SYSTEMATIC REVIEW
Published on 09 Jul 2024
Immune-related adverse events in patients treated with immunotherapy for locally advanced or metastatic NSCLC in real-world settings: a systematic review and meta-analysis
doi 10.3389/fonc.2024.1415470
- 1,841 views
- 3 citations
ORIGINAL RESEARCH
Published on 25 Jun 2024
Pulmonary function test-related prognostic models in non-small cell lung cancer patients receiving neoadjuvant chemoimmunotherapy
doi 10.3389/fonc.2024.1411436
- 1,184 views
